| Q36106833 | A New Look at Care in Pregnancy: Simple, Effective Interventions for Neglected Populations |
| Q34425568 | A Systematic Review of Nutritional Supplementation in HIV-Infected Children in Resource-Limited Settings. |
| Q33592344 | A randomized trial to determine the optimal dosage of multivitamin supplements to reduce adverse pregnancy outcomes among HIV-infected women in Tanzania |
| Q33377311 | A systematic review of randomized controlled trials of prenatal and postnatal vitamin A supplementation of HIV-infected women |
| Q35828573 | A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat |
| Q36004865 | A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection |
| Q35140513 | Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants |
| Q26860516 | An enigma: why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality |
| Q38060232 | An evidence-based systematic review of vitamin A by the natural standard research collaboration |
| Q95643468 | Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy |
| Q36553987 | CXCR4-tropic, but not CCR5-tropic, human immunodeficiency virus infection is inhibited by the lipid raft-associated factors, acyclic retinoid analogs, and cholera toxin B subunit |
| Q38960638 | Child Growth According to Maternal and Child HIV Status in Zimbabwe |
| Q28731813 | Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis |
| Q46329886 | Comment on: 'Maternal postpartum vitamin A supplementation for the prevention of mortality and morbidity in infancy: a systematic review of randomised controlled trials' |
| Q46844036 | Conflicting evidence for neonatal vitamin A supplementation |
| Q34734281 | Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants |
| Q43928569 | Considerations in developing lipid-based nutrient supplements for prevention of undernutrition: experience from the International Lipid-Based Nutrient Supplements (iLiNS) Project |
| Q30377601 | Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus-Exposed Uninfected Zimbabwean Infants. |
| Q37641587 | Double standards in research ethics, health-care safety, and scientific rigour allowed Africa's HIV/AIDS epidemic disasters |
| Q62488719 | Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials |
| Q36728924 | Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial |
| Q34119949 | Effect of vitamin supplements on HIV shedding in breast milk |
| Q34609629 | Effects of vitamins, including vitamin A, on HIV/AIDS patients |
| Q45020926 | Elevated iron stores are associated with HIV disease severity and mortality among postpartum women in Zimbabwe |
| Q33509011 | Functional genetic variants in DC-SIGNR are associated with mother-to-child transmission of HIV-1 |
| Q46308769 | HIV-1 and HIV-2 prevalence and associated risk factors among postnatal women in Harare, Zimbabwe |
| Q30383065 | HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era. |
| Q33446714 | HIV: mother-to-child transmission |
| Q33866493 | HIV: prevention of mother-to-child transmission. |
| Q30381646 | Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy era |
| Q57953987 | Hepcidin decreases over the first year of life in healthy African infants |
| Q56839521 | Heterogeneous effects on child survival in neonatal vitamin A supplementation trials |
| Q26864779 | Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms |
| Q34482675 | How should we best estimate the mean recency duration for the BED method? |
| Q35165325 | In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infection |
| Q45274141 | Increased receptor for advanced glycation endproducts immunocontent in the cerebral cortex of vitamin A-treated rats |
| Q26830867 | Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). |
| Q59325084 | Influence of inflammation as measured by α-1-acid glycoprotein on iron status indicators among HIV-positive postpartum Zimbabwean women |
| Q92404777 | Influences of Vitamin A on Vaccine Immunogenicity and Efficacy |
| Q34266696 | Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau |
| Q41932805 | Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants |
| Q64120838 | Lessons Learned from the Testing of Neonatal Vitamin A Supplementation |
| Q37428096 | Linear growth trajectories in Zimbabwean infants |
| Q35029241 | Maternal multivitamin supplementation reduces the risk of diarrhoea among HIV-exposed children through age 5 years |
| Q36687056 | Micronutrient interventions and HIV infection: a review of current evidence |
| Q37420786 | Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial |
| Q24235504 | Micronutrient supplementation in children and adults with HIV infection |
| Q22241202 | Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations? |
| Q45073085 | Modelling stunting in LiST: the effect of applying smoothing to linear growth data |
| Q28744042 | Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study |
| Q42100861 | Multicomponent synthesis of spiropyrrolidine analogues derived from vinylindole/indazole by a 1,3-dipolar cycloaddition reaction |
| Q37098421 | Multivitamin supplementation improves haematologic status in children born to HIV-positive women in Tanzania |
| Q28727311 | Naturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmission |
| Q25255691 | Neonatal erythropoiesis and subsequent anemia in HIV-positive and HIV-negative Zimbabwean babies during the first year of life: a longitudinal study |
| Q46331005 | Neonatal period: linking best nutrition practices at birth to optimize maternal and infant health and survival |
| Q62487995 | Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants |
| Q57954037 | Neonatal vitamin A supplementation and infant survival |
| Q34538677 | Neonatal vitamin A supplementation associated with a cluster of deaths and poor early growth in a randomised trial among low-birth-weight boys of vitamin A versus oral polio vaccine at birth |
| Q53801389 | Neonatal vitamin A supplementation associated with increased atopy in girls. |
| Q24235939 | Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in developing countries |
| Q38943950 | Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries |
| Q33797490 | Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa |
| Q36513326 | New challenges in studying nutrition-disease interactions in the developing world. |
| Q47285726 | No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau |
| Q37702501 | Nutrition, intestinal defence and the microbiome |
| Q28385340 | Plasma Concentrations of Hepcidin in Anemic Zimbabwean Infants |
| Q35060305 | Postpartum plasma CD4 change in HIV-positive women: implications for timing of HAART initiation |
| Q35625896 | Predictive value of weight loss on mortality of HIV-positive mothers in a prolonged breastfeeding setting |
| Q24234778 | Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection |
| Q33516173 | Reconciling conflicting clinical studies of antioxidant supplementation as HIV therapy: a mathematical approach |
| Q35940739 | Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice |
| Q36051649 | Role of nutrients in the development of neonatal immune response |
| Q46210436 | Serious danger signals: Response to: The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial |
| Q34996528 | Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania |
| Q37379347 | Stunting Mediates the Association between Small-for-Gestational-Age and Postneonatal Mortality |
| Q35099463 | Stunting is characterized by chronic inflammation in Zimbabwean infants |
| Q57469456 | The Cochrane Library and mother-to-child transmission of HIV: an umbrella review |
| Q35557264 | The effect of aging, nutrition, and exercise during HIV infection |
| Q46848449 | The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination |
| Q40478764 | The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial. |
| Q35315240 | The effect of postpartum vitamin A supplementation on breast milk immune regulators and infant immune functions: study protocol of a randomized, controlled trial |
| Q40419056 | The effect of vitamin A status in children treated for cancer |
| Q46249626 | The effects of maternal and infant vitamin A supplementation on vitamin A status: a randomised trial in Kenya. |
| Q56970313 | The impact of safer breastfeeding practices on postnatal HIV-1 transmission in Zimbabwe |
| Q38547857 | The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applications |
| Q46385836 | Two different doses of supplemental vitamin A did not affect mortality of normal-birth-weight neonates in Guinea-Bissau in a randomized controlled trial |
| Q28081121 | Vitamin A and Retinoids as Mitochondrial Toxicants |
| Q37349732 | Vitamin A and carotenoids during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis |
| Q33988852 | Vitamin A and vitamin B-12 concentrations in relation to mortality and morbidity among children born to HIV-infected women |
| Q34421374 | Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat. |
| Q33716753 | Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
| Q34092724 | Vitamin A supplementation and neonatal mortality in the developing world: a meta-regression of cluster-randomized trials |
| Q24186343 | Vitamin A supplementation during pregnancy for maternal and newborn outcomes |
| Q24236618 | Vitamin A supplementation during pregnancy for maternal and newborn outcomes |
| Q24186006 | Vitamin A supplementation for postpartum women |
| Q24234927 | Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection |
| Q24245896 | Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection |
| Q34541369 | Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age. |
| Q24236185 | Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less |
| Q51014857 | Vitamin A supplementation for the reduction of the risk of mother-to-child transmission of HIV. |
| Q40053700 | Vitamin A supplements for reducing mother-to-child HIV transmission |